Community Buprenorphine Continuation Post-Release Following Extended Release Vs. Sublingual Buprenorphine During Incarceration: A Pilot Project in Maine

View Resource

Compares post-release outcomes among incarcerated people who received extended-release buprenorphine (XRB) versus sublingual buprenorphine (SLB) for opioid use disorder (OUD) in rural Maine jails. Includes data from two jails, one of which had implemented an XRB pilot program, on rates of post-release community buprenorphine treatment continuation, diversion, safety concerns, XRB side effects, and post-release mortality.

Alane B. O'Connor, Catherine Gelsinger, Sadie M. Donovan, Jessica Marshall, Katherine A. Ahrens

Health & Justice, 12, 28

06/2024

Document

Criminal justice system · Healthcare quality · Illicit drug use · Mortality · Pharmacy and prescription drugs · Prescription drug misuse · Statistics and data · Substance use and misuse · Maine